Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
1. 系统已在2025-12-26 16:17:13对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2213-8587(22)00243-1
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213858722002431
其他信息:
出版社: Elsevier BV
作者: Hiddo J L Heerspink; Naveed Sattar; Imre Pavo; Axel Haupt; Kevin L Duffin; Zhengyu Yang; Russell J Wiese; Katherine R Tuttle; David Z I Cherney

